Natalia Vtyurina was trained in Russia as a fundamental physicist at Lomonosov Moscow State University (2011). She successfully graduated as a PhD in biophysics from Bionanoscience department at Delft University of Technology (2016) where she studied DNA-protein interactions at the single-molecule level.
This experience prompted her to proceed further towards a new challenge in biomedical research. With the ultimate purpose of discovering how to maximize the delivery efficiency of engineered nano-sized drug carriers, she has completed postdoctoral research project in the field of nanomedicines at University of Groningen (2019) under supervision of Dr. Anna Salvati. Within this project she was building up a live-cell imaging platform to characterize internalization and trafficking of nanoparticles by human cells.
Being social and communicative she is actively contributing to dynamic, fast moving and multicultural environment of the Controlled Release Society (CRS). In February 2019 she established a new CRS BeNeLux & France Local Chapter and in April 2019 was elected to be a president of this non-profit scientific organization.
In November 2019, Natalia made a transition from academia to industry and joined ProPharma Group in Leiden, the Netherlands as an Associate Consultant. After executing assignments and projects in Product Life Cycle team she has gained an experience in GMP, Internal Standards, Qualification and Validation, IQ, PQ, Medical Devices, Data Integrity. From January 2021 she continued her career journey by joining brand new Contract and Development Manufacturing Organization (CDMO) Halix B.V. as a Quality Assurance (QA) Officer.